Abstract
Introduction
Nocodazole interferes with microtubule assembly [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] thus interfering with mitosis due to formation of multipolar spindles [15, 16] and leading to cell cycle arrest in G2/M [8, [17] [18] [19] . Moreover, nocodazole causes cellular bulging and/or bending [20] . By interacting with microtubule function [21] nocodazole or related substances trigger caspaseindependent mitotic death [22] or caspase dependent apoptosis [2, 5, 7, 10, 13, 16, 17, [23] [24] [25] [26] [27] [28] . The triggering of apoptosis involves downregulation of mTOR [29] , inactivation of the antiapoptotic Bcl-2 [2, 4, 23, 29] and mitochondrial depolarization [23] . Nocodazole is thus effective against malignancy [2, 5, 14, 15, 17, 21] . On the other hand, nocodazole counteracts TNF-α-induced activation of the mitogen-activated protein kinase p38 [30] .
Similar to apoptosis of nucleated cells, erythrocytes may enter eryptosis [31] , the suicidal death of erythrocytes characterized by cell shrinkage [32] and cell membrane scrambling with phosphatidylserine translocation to the cell surface [31] . Triggers of eryptosis include increase of cytosolic Ca 2+ activity ([Ca   2+ ] i ), ceramide [33] , oxidative stress [31] , energy depletion [31] activated caspases [34, 35] , stimulated activity of casein kinase 1α, Janusactivated kinase JAK3, protein kinase C, and p38 kinase [31] , as well as impaired activity of AMP activated kinase AMPK, cGMP-dependent protein kinase, PAK2 kinase, mitogen-and stress-activated kinase MSK1/2 and sorafenib/sunitinib sensitive kinases [31, 36] .
The present study explored whether nocodazole induces eryptosis. To this end, human erythrocytes from healthy volunteers were treated with nocodazole and phosphatidylserine surface abundance, cell volume, [Ca 2+ ] i , reactive oxygen species (ROS) and ceramide abundance determined by flow cytometry.
Materials and Methods

Erythrocytes, solutions and chemicals
Fresh Li-Heparin-anticoagulated blood samples were kindly provided by the blood bank of the University of Tübingen. The study is approved by the ethics committee of the University of Tübingen (184/2003 V). The blood was centrifuged at 120 g for 20 min at 21°C and the platelets and leukocytes-containing supernatant was disposed. Erythrocytes were incubated in vitro at a hematocrit of 0.4% in Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO 4 , 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES; pH 7.4), 5 glucose, 1 CaCl 2 , at 37°C for 48 h. Where indicated, erythrocytes were exposed to nocodazole (Sigma Aldrich, Hamburg, Germany) at the indicated concentrations.
Annexin-V-binding and forward scatter
After incubation under the respective experimental condition, 100 µl cell suspension was washed in Ringer solution containing 5 mM CaCl 2 and then stained with Annexin-V-FITC (1:200 dilution; ImmunoTools, Friesoythe, Germany) in this solution at 37°C for 20 min under protection from light. The annexin-V abundance at the erythrocyte surface was subsequently determined on a FACS Calibur (BD, Heidelberg, Germany). A dot plot of forward scatter (FSC) vs. side scatter (SSC) was set to linear scale for both parameters. The threshold of forward scatter was set at the default value of "52". 
Intracellular Ca
Measurement of hemolysis
For the determination of hemolysis, the samples were centrifuged (10 min at 2000 rpm, room temperature) and the supernatants were collected. As a measure of hemolysis, the hemoglobin (Hb) concentration of the supernatant was determined photometrically at 405 nm. The absorption of the supernatant of erythrocytes lysed in distilled water was defined as 100% hemolysis.
Reactive oxidant species (ROS)
Oxidative stress was determined utilizing 2',7'-dichlorodihydrofluorescein diacetate (DCFDA). After incubation, a 100 µl suspension of erythrocytes was washed in Ringer solution and then stained with DCFDA (Sigma, Schnelldorf, Germany) in PBS containing DCFDA at a final concentration of 10 µM. Erythrocytes were incubated at 37°C for 30 min in the dark and then washed in PBS. The DCFDA-loaded erythrocytes were resuspended in 200 µl Ringer solution, and ROS-dependent fluorescence intensity was measured at an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur (BD).
Ceramide abundance
For the determination of ceramide, a monoclonal antibody-based assay was used. After incubation, cells were stained for 1 hour at 37°C with 1 µg/ml anti ceramide antibody (clone MID 15B4, Alexis, Grünberg, Germany) in PBS containing 0.1% bovine serum albumin (BSA) at a dilution of 1:10. The samples were washed twice with PBS-BSA. Subsequently, the cells were stained for 30 minutes with polyclonal fluorescein isothiocyanate (FITC) conjugated goat anti-mouse IgG and IgM specific antibody (Pharmingen, Hamburg, Germany) diluted 1:50 in PBS-BSA. Unbound secondary antibody was removed by repeated washing with PBS-BSA. The samples were then analyzed by flow cytometric analysis with an excitation wavelength of 488 nm and an emission wavelength of 530 nm.
Tubulin staining
For studying the effect of nocodazole on tubulin in human erythrocytes TubulinTracker™ Green reagent (Oregon Green® 488 Taxol; bis-acetate, Thermo Fisher Scientific, MA, USA) was used. Briefly, treated samples were stained with TubulinTracker (250 nM) for 30 min in the dark at 37°C. The erythrocytes were washed twice and finally resuspended in 200 μl Ringer solution containing 5 mM CaCl 2 . For flow cytometry, TubulinTracker-dependent fluorescence of the samples was measured with an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur (BD). For confocal microscopy, 60 μl of each sample were spread onto a glass slide and dried for 15 minutes at RT. The slides were covered with PROlong Gold antifade reagent (Invitrogen, Darmstadt Germany). Images were taken on a Zeiss LSM 5 EXCITER confocal laser-scanning microscope or with phase light (Carl Zeiss MicroImaging, Germany) with a water immersion Plan-Neofluar 63/1.3 NA DIC.
Statistics
Data are expressed as arithmetic means ± SEM. As indicated in the figure legends, statistical analysis was made using ANOVA with Tukey's test as post-test and t test as appropriate. n denotes the number of different erythrocyte specimens studied. Since different erythrocyte specimens used in distinct experiments are differently susceptible to triggers of eryptosis, the same erythrocyte specimens have been used for control and experimental conditions.
Results
The present study aimed to possibly disclose an effect of nocodazole on eryptosis, the suicidal erythrocyte death characterized by cell shrinkage and cell membrane scrambling with phosphatidylserine translocation to the cell surface. In order to identify phosphatidylserine exposing erythrocytes the erythrocytes were incubated with annexin-V which tightly binds to surface phosphatidylserine. Annexin-V abundance was quantified by flow cytometry. The measurements were made following a 48 hours incubation in Ringer solution without or with nocodazole (15 -60 µg/ml). As illustrated in Fig. 1 , a 48 hours exposure to nocodazole increased the percentage of phosphatidylserine exposing erythrocytes, an effect reaching statistical significance at 30 µg/ml nocodazole.
In order to estimate erythrocyte volume, forward scatter was determined utilizing flow cytometry following a 48 hours incubation in Ringer solution without or with nocodazole (15 -60 µg/ml). As shown in Fig. 2 , at none of the applied concentrations, nocodazole had a significant effect on average erythrocyte forward scatter. Close inspection of Fig. 2A reveals, however, that exposure of erythrocytes to nocodazole was followed by an increase of the percentage of both small (Fig. 2C ) and large (Fig. 2D) erythrocytes, alterations reaching significance at nocodazole concentrations of 60 µg/ml.
Hemolysis was estimated from the hemoglobin concentration in the supernatant which was determined by photometry. As a result, following a 48 hours incubation, the percentage of hemolytic erythrocytes was similar in the absence of nocodazole (3.4 ± 0.2% n = 12) and in the presence of 15 µg/ml (4.4 ± 0.2% n = 12) or 30 µg/ml (4.7 ± 0.2% n = 12) nocodazole. Exposure to 60 µg/ml nocodazole was, however, followed by a significant increase of hemolysis (11.1 ± 0.9% n = 12).
Cytosolic Ca 2+ activity ([Ca   2+ ] i ) was determined by Fluo3-fluorescence. As illustrated in Fig. 3 , a 48 hours exposure to nocodazole increased the Fluo3-fluorescence, an effect reaching statistical significance at 60 µg/ml nocodazole. In order to test whether the stimulation of cell membrane scrambling by nocodazole requires the entry of extracellular Ca 2+ , erythrocytes were incubated for 48 hours in the absence or presence of 60 µg/ml nocodazole in the presence or nominal absence of extracellular Ca 2+ . As shown in Fig. 4 ] i on cell membrane scrambling or forward scatter, erythrocytes were exposed for 60 min to Ca 2+ ionophore ionomycin (1 µM). As a result, ionomycin increased the percentage of annexin-V-binding erythrocytes to similarly high levels in erythrocytes incubated with nocodazole (from 4.8 ± 0.3% to 35.8 ± 1.6% n = 4) and in erythrocytes incubated without nocodazole (from 1.6 ± 0.2% to 38.7 ± 1.8% n = 4). Ionomycin decreased the forward scatter to similarly low levels in erythrocytes incubated with nocodazole (from 432 ± 8.8% to 124 ± 1.9%, n = 4) and in erythrocytes incubated without nocodazole (from 440 ± 8.8% to 123 ± 4.4%, n = 4).
Additional experiments were performed to elucidate the effect of nocodazole on oxidative stress. Reactive oxygen species (ROS) were estimated utilizing 2′,7′-dichlorodihydrofluorescein (DCF) diacetate. As illustrated in Fig. 5 , a 48 hours exposure to nocodazole increased the DCF fluorescence, an effect reaching statistical significance at 30 µg/ml nocodazole. Eryptosis could further be stimulated by ceramide. Ceramide abundance at the erythrocyte surface was thus quantified with flow cytometry utilizing specific antibodies. As illustrated in Fig. 6 , a 48 hours exposure to nocodazole (60 µg/ml) significantly increased the ceramide abundance.
To investigate the effect of nocodazole on tubulin in erythrocytes, TubulinTracker reagent was utilized in both flow cytometry and confocal microscopy. As illustrated in Fig.  7 , 48 h treatment of erythrocytes with nocodazole (60 µg/ml) significantly reduced the TubulinTracker-dependent fluorescence.
To explore whether the stimulation of cell membrane scrambling by nocodazole required caspase activity, erythrocytes were exposed for 48 h to 60 μg/ml nocodazole either in the absence or presence of the pancaspase inhibitor zVAD (1 μM). As illustrated in Fig. 8 , zVAD did not significantly modify the effect of nocodazole on annexin-V-binding.
Discussion
The present observations demonstrate that nocodazole triggers cell membrane scrambling, the key event of suicidal erythrocyte death or eryptosis. The concentrations required for the toxic effect are higher than those required for disassembly of microtubules [13] but are similar to those previously employed to trigger cell cycle arrest [37] .
The sensitivity to nocodazole may be particularly high in clinical conditions associated with enhanced eryptosis, such as dehydration [38] , hyperphosphatemia [39] chronic kidney disease (CKD) [40] [41] [42] [43] , hemolytic-uremic syndrome [44] , diabetes [45] , hepatic failure [46] , cardiac failure [47] , malignancy [48] , sepsis [49] , fever [31, 50] , sickle-cell disease [31] , betathalassemia [31] , Hb-C and G6PD-deficiency [31] , Wilsons disease [51] as well as advanced age [52] . Moreover, the effect of nocodazole may be compounded by other eryptosis stimulating xenobiotics [38, 39, 41, 48, .
The stimulation by nocodazole of cell membrane scrambling was in part due to increase of cytosolic Ca 2+ activity ([Ca   2+ ] i ) and was thus significantly blunted by removal of extracellular Ca 2+ . However, even in the absence of extracellular Ca 2+ nocodazole treatment was followed by stimulation of cell membrane scrambling, pointing to additional mechanisms in the stimulation of eryptosis by nocodazole. Those mechanisms presumably include oxidative stress and ceramide.
Nocodazole did not significantly modify the average forward scatter but increased the percentage of both, shrunken and swollen erythrocytes. The cell shrinkage could be explained at least partially by increase of [Ca 2+ ] i with subsequent activation of Ca 2+ sensitive K + channels, K + exit, cell membrane hyperpolarization, Cl -exit and thus cellular loss of KCl with water [32] . The mechanism driving nocodazole induced erythrocyte swelling remains elusive. A candidate mechanism could be impairment of Na + /K + ATPase with subsequent cellular accumulation of Na + with Cl -. Whatever mechanism is involved in nocodazole induced cell swelling, it leads to swelling of only a small subset of erythrocytes.
We observed a moderate decrease of tubulin abundance following nocodazole treatment. Whether this effect contributes to the stimulation of eryptosis, remains uncertain. In blood platelets Ca 2+ induced apoptosis was seemingly insensitive to cytoskeletal rearrangement [107] .
The nocodazole induced eryptosis was insensitive to the pancaspase inhibitor zVAD. Accordingly, the stimulation of cell membrane scrambling by nocodazole does apparently Fig. 8 . Insensitivity of nocodazole induced phosphatidylserine exposure to caspase inhibitor zVAD. Arithmetic means ± SEM (n = 9) of the percentage of annexin-V-binding erythrocytes following incubation for 48 hours to Ringer solution without (white bars) or with (black bars) nocodazole (60 µg/ml) treatment in the absence (-zVAD) or presence (+zVAD) of the pancaspase inhibitor zVAD (1 µM). ***(p<0.001) indicates significant difference from the absence of nocodazole (ANOVA).
